Minimally Invasive Surgical Instrument Patent Landscape
Minimally Invasive Surgical Instrument Patent Landscape in 2026
The minimally invasive surgical instrument space is highly concentrated, with a small cluster of large-cap medtech incumbents — led by Cilag GmbH International and Intuitive Surgical Operations — accounting for a dominant share of filings. Annual volume peaked in 2017 and has since eased, placing the field in a declining phase where incremental differentiation and adjacent technical branches offer the clearest entry points.
A concentrated field led by established medtech incumbents
Cilag GmbH International holds the top position in the ranking, followed by Intuitive Surgical Operations and Boston Scientific Scimed. These three leaders alone account for a substantial portion of activity among the hundred largest filers, reflecting a field where large integrated medtech companies have built deep portfolios over many years.
The top five filers collectively hold 34% of the combined patent records of the hundred largest filers, signaling meaningful but not extreme concentration. A clear tier gap separates the top three from the mid-table applicants, with the fourth and fifth ranked filers — Symbiosis Corp and Intrapace Inc — trailing the leaders by a significant margin.
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 1 | Cilag GmbH International | 246 | |
| 2 | Intuitive Surgical Operations Inc | 188 | |
| 3 | Boston Scientific Scimed Inc | 133 | |
| 4 | Symbiosis Corp | 85 | |
| 5 | Intrapace Inc | 84 | |
| 6 | Ethicon Endo Surgery Inc | 75 | |
| 7 | Ethicon Inc | 72 | |
| 8 | Vioptix Inc | 68 | |
| 9 | Auris Health Inc | 66 | |
| 10 | Biosense Webster Inc | 65 |
| # | Applicant | Patent records | Share |
|---|---|---|---|
| 11 | Fortimedix Assets II BV | 61 | |
| 12 | Richard Wolf GmbH | 36 | |
| 13 | The Cleveland Clinic Foundation | 35 | |
| 14 | Dabegran Technologies | 33 | |
| 15 | United States Surgical Corp | 31 | |
| 16 | United States Endoscopy Group Inc | 30 | |
| 17 | Boston Scientific Ltd | 29 | |
| 18 | Koninklijke Philips NV | 27 | |
| 19 | Medtronic Inc | 26 | |
| 20 | New World Medical Inc | 24 |
The leaders’ positions reflect decades of platform investment in surgical tools, robotic assistance, and fluid-management devices. This depth of portfolio makes displacement of the top tier through incremental improvement unlikely; new entrants are more likely to find traction in adjacent sub-classes where dominant incumbents have thinner coverage.
Filing counts for the most recent 18–24 months are subject to publication lag and will rise as applications publish; the apparent low counts in 2024–2026 should not be interpreted as a further acceleration of decline. Longer-window growth, applicant concentration, and technology-route coverage are therefore more reliable signals than the latest-year bar alone.
Peak activity in 2017, broad surgical-instrument core, sparse robotic and digital adjacencies
The annual filing trend reveals a field that crested in 2017 and has moderated since, while the technology composition chart shows an overwhelming concentration in core surgical and fluid-management classes alongside a long tail of under-populated adjacent branches.
Annual filing trend
Filings reached their highest recorded level in 2017 at 187 patent records and have trended lower since, with a modest recovery in 2022 before further easing. Counts from 2024 onward are materially under-reported due to publication lag and do not represent the true pace of current activity.
↗ Hover for values · click a bar to ask EurekaTechnology composition
The portfolio is anchored in A61B (diagnosis and surgery) and A61M (devices for body fluids), which together account for the overwhelming majority of classified records. Classes covering robotics and manipulators (B25J), image processing (G06T), material analysis (G01N), implants (A61F), and electrotherapy (A61N) are present but comparatively sparse, highlighting where the technical frontier remains less contested.
↗ Hover for values · click a bar to ask EurekaHighly cited patent families surfaced by the query
Citation-heavy patent families returned by the query. Use this section as citation context, not as a curated list of the most topic-specific patents.
Minimally invasive surgical instrument having arti…
The present invention relates to a minimally invasive surgical instrument having an articulation immobilising structure. The present invention is a s minimally invasive surgical instrument and includes a shaft, an end effector connected towards one end of the shaft, a wire for controlling the articulated movement of the end effector, and an immobilising… (excerpt from the patent abstract)
| # | Patent | Citations |
|---|---|---|
| 1 | Magnetic determination of position and orientation | 2,314 |
| 2 | Gastric treatment and diagnosis device and method | 2,212 |
| 3 | Automated surgical system and apparatus | 2,179 |
| 4 | Surgical instrument with bending articulation cont… | 2,151 |
| 5 | Method and apparatus for performing biopsy | 2,142 |
| 6 | Surgical instrument for endoscopic and general sur… | 1,972 |
| 7 | Endoscopic ultrasonic aspirators | 1,951 |
| 8 | Endoscopic robotic surgical tools and methods | 1,928 |
Ranked by total forward citations. Citation counts favour older and broadly cited patent families, and broad or adjacent patents may appear when they match the search scope. Treat this section as citation context, not as a curated list of the most topic-specific patents. Some patent titles may be shown in their original, non-English language where an accurate translation could not be guaranteed.
What the competitive structure means for R&D investment
Four structural observations — maturity, concentration, collaboration, and geography — define where risk and opportunity sit in this landscape.
Field is in decline phase: annual volume has eased from the 2017 peak
The lifecycle evidence places this field in a decline stage, with annual filings easing back from the 2017 peak and a recent-window growth rate of –29%. This does not preclude continued innovation, but it suggests the broad platform of surgical instrument patents is maturing. R&D investment is most defensible when targeted at differentiated sub-classes rather than the already-crowded core A61B surgical tools space.
Lifecycle: DeclineTop five hold 34% of the hundred largest filers’ combined records
The top five applicants — Cilag GmbH International, Intuitive Surgical Operations, Boston Scientific Scimed, Symbiosis Corp, and Intrapace Inc — collectively hold 34% of the patent records among the hundred largest filers. A clear tier gap exists between the top three and the rest of the field. For a new entrant, competing head-on with these incumbents on core surgical instrument IP is a high-barrier strategy; adjacent classes offer a lower-density alternative.
High concentrationBiosense Webster and Lawrence Livermore National Security are the most active co-filers
The most active co-filing pair is Biosense Webster and Lawrence Livermore National Security with 11 joint records, suggesting a government-lab-to-industry technology transfer channel in sensing and navigation. Ethicon Endo Surgery and the University of Massachusetts co-filed 3 records, pointing to an academic-industrial collaboration path. Boston Scientific Scimed and Boston Scientific Miami Corp share 1 joint record. These partnerships span industry-lab and industry-academic models and may indicate licensing or development programs worth monitoring.
Cross-sector co-filingUS-centric filing with selective European and PCT coverage
The United States is the dominant filing jurisdiction, followed by the European Patent Office and WIPO PCT routes. Australia and Canada rank fourth and fifth respectively, reflecting standard English-language market coverage. China, despite being a major surgical device market, sits at a comparatively low count, which may indicate an under-protection gap or a strategic choice by incumbents. South Korea and Japan are present but sparse, suggesting limited near-term competitive pressure from Asian filers in this corpus.
US-centricGo beyond the landscape: Eureka’s TRIZ Solution agent breaks down an R&D problem and returns patented concept solutions, each with a technical approach and cited patent & literature evidence.
| Applicant | Collaborator | Co-filings |
|---|---|---|
| Biosense Webster Inc | Lawrence Livermore National Security LLC | 11 |
| Ethicon Endo Surgery Inc | University of Massachusetts | 3 |
| Boston Scientific Scimed Inc | Boston Scientific Miami Corp | 1 |
Co-filing pairs, ranked by the number of jointly-filed patent families.
Cilag and Intuitive Surgical lead; Cilag momentum accelerating
The two leading applicants differ in their technology emphasis and recent filing trajectories, with Cilag GmbH International showing accelerating momentum while Intuitive Surgical Operations shows a modest contraction.
Cilag GmbH International
Cilag GmbH International ranks first with 246 patent records and is showing accelerating recent activity at 3.5× its prior three-year pace, the strongest momentum signal among the top applicants. Its technology emphasis concentrates on A61B 17 (surgical instruments), A61B 34 (robotic and computer-assisted surgery), and A61B 50 (surgical ancillaries), reflecting a broad platform strategy across both manual and assisted-surgery tools.
patent records: 246Intuitive Surgical Operations
Intuitive Surgical Operations ranks second with 188 patent records and a recent trend of –10% versus the prior period. Its technical focus centres on A61B 34 (robotic and computer-assisted surgery), A61B 17 (surgical instruments), and A61B 90 (surgical accessories and navigation), consistent with its robotic platform strategy. The mild decline in recent filings may reflect portfolio consolidation rather than a strategic retreat, given the publication-lag caveat applicable to recent years.
patent records: 188| Applicant | Recent (3 yrs) | Trend |
|---|---|---|
| Intuitive Surgical Operations Inc | 27 | ▼ -10% |
| Covidien LP | 3 | ▲ new entrant |
| Boston Scientific Scimed Inc | 9 | ▲ new entrant |
| Vioptix Inc | 12 | ▼ -25% |
| Cilag GmbH International | 38 | ▲ 3.5× vs prior 3-yr |
Under-served branches: robotics, image processing, and electrotherapy
Several IPC classes appear in the corpus at low relative share, sitting adjacent to the dominant surgical-instrument core. These are observations of relative sparsity; the three discussed below also carry plausible technical relevance and realistic entry paths for teams already active in surgical instruments.
B25J · Manipulators & robots
B25J accounts for only 1% of classified records in this corpus despite robotics being a recognized growth area in minimally invasive surgery. The sparsity likely reflects that most robotic surgical IP is filed under A61B 34 rather than the general industrial-robot class; however, teams developing novel end-effector mechanics, force-feedback actuators, or cable-driven joints that draw on broader robotics prior art may find this branch less congested and strategically useful for cross-domain protection.
Search this in Eureka →G06T · Image data processing & generation
G06T represents approximately 1% of records, signaling that computational imaging — including intraoperative image enhancement, tissue segmentation, and augmented-reality overlay for endoscopic guidance — remains sparsely protected within this corpus relative to the hardware classes. As surgical workflows increasingly incorporate AI-assisted vision, teams with expertise in medical image processing could file in G06T alongside A61B to build a cross-disciplinary position that incumbent hardware-focused filers have not yet densely occupied.
Search this in Eureka →How leaders differ by technology route
Strength of each leader across the main technology routes.
| Player | A61B 17 · Diagnosis & surgery | A61B 1 · Diagnosis & surgery | A61M 25 · Devices for body fluids | A61B 5 · Diagnosis & surgery | A61B 34 · Diagnosis & surgery |
|---|---|---|---|---|---|
| Intuitive Surgical Operations Inc | Strong · 121 | Strong · 75 | Strong · 83 | Moderate · 63 | Strong · 139 |
| Ethicon Inc | Strong · 195 | Absent | Absent | Absent | Strong · 130 |
| Boston Scientific Scimed Inc | Strong · 58 | Strong · 67 | Strong · 62 | Absent | Absent |
| Intrapace Inc | Strong · 68 | Absent | Strong · 58 | Absent | Absent |
| Covidien LP | Strong · 49 | Strong · 26 | Absent | Strong · 34 | Moderate · 12 |
| Biosense Webster Inc | Absent | Strong · 26 | Strong · 51 | Strong · 44 | Absent |
| Fortimedix Assets II BV | Strong · 30 | Strong · 44 | Strong · 45 | Absent | Absent |
Frequently asked questions
The corpus covers 1,038 patent families. This is the base count for the landscape; applicant rankings are reported in patent records, which can exceed the family total because a single family may be counted across multiple applicants or jurisdictions.
Cilag GmbH International leads the ranking with 246 patent records, followed by Intuitive Surgical Operations with 188 and Boston Scientific Scimed with 133. Cilag also shows the strongest recent momentum among the top filers, at 3.5× its prior three-year pace.
The evidence places the field in a decline stage. Annual filings peaked in 2017 at 187 patent records and have eased since, with a recent-window growth rate of -29%. Note that the most recent 18–24 months of data are under-counted due to publication lag.
The United States is the dominant jurisdiction, followed by the European Patent Office and WIPO PCT routes. Australia and Canada rank fourth and fifth. China is present but at a comparatively low count relative to its market size, which may represent an under-protection gap worth investigating.
The top-cited works cover magnetic position determination, gastric treatment and diagnosis devices, automated surgical systems, bending-articulation surgical instruments, biopsy methods and apparatus, endoscopic surgical instruments, endoscopic ultrasonic aspirators, and endoscopic robotic surgical tools. These reflect the core navigation, tissue-interaction, and robotic-assistance themes that underpin the field.
The whitespace analysis identifies five branches with low relative share: A61F (implants and prostheses) at 4%, A61N (electrotherapy and radiation therapy) at 4%, B25J (manipulators and robots) at 1%, G06T (image data processing) at 1%, and G01N (material analysis and testing) at 1%. Robotics (B25J) and computational imaging (G06T) are particularly sparse given their technical relevance to the field’s direction.
Ready to map your own minimally invasive surgical instrument landscape?
Join 18,000+ innovators using PatSnap Eureka to map any technology landscape: search 2B+ patents and papers, surface key assignees, and generate a report like this in minutes.
Disclaimer. This page is generated from PatSnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. PatSnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.